1. Home
  2. MIST vs AMPY Comparison

MIST vs AMPY Comparison

Compare MIST & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • AMPY
  • Stock Information
  • Founded
  • MIST 2003
  • AMPY 2011
  • Country
  • MIST Canada
  • AMPY United States
  • Employees
  • MIST N/A
  • AMPY N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • AMPY Oil & Gas Production
  • Sector
  • MIST Health Care
  • AMPY Energy
  • Exchange
  • MIST Nasdaq
  • AMPY Nasdaq
  • Market Cap
  • MIST 145.3M
  • AMPY 164.7M
  • IPO Year
  • MIST N/A
  • AMPY 2011
  • Fundamental
  • Price
  • MIST $1.96
  • AMPY $3.98
  • Analyst Decision
  • MIST Strong Buy
  • AMPY Strong Buy
  • Analyst Count
  • MIST 3
  • AMPY 1
  • Target Price
  • MIST $6.33
  • AMPY $11.00
  • AVG Volume (30 Days)
  • MIST 1.2M
  • AMPY 443.2K
  • Earning Date
  • MIST 11-11-2025
  • AMPY 11-05-2025
  • Dividend Yield
  • MIST N/A
  • AMPY N/A
  • EPS Growth
  • MIST N/A
  • AMPY N/A
  • EPS
  • MIST N/A
  • AMPY 0.38
  • Revenue
  • MIST N/A
  • AMPY $279,289,100.00
  • Revenue This Year
  • MIST N/A
  • AMPY $2.33
  • Revenue Next Year
  • MIST N/A
  • AMPY N/A
  • P/E Ratio
  • MIST N/A
  • AMPY $10.55
  • Revenue Growth
  • MIST N/A
  • AMPY N/A
  • 52 Week Low
  • MIST $0.63
  • AMPY $2.27
  • 52 Week High
  • MIST $2.75
  • AMPY $7.35
  • Technical
  • Relative Strength Index (RSI)
  • MIST 66.84
  • AMPY 53.56
  • Support Level
  • MIST $1.75
  • AMPY $3.72
  • Resistance Level
  • MIST $1.83
  • AMPY $4.01
  • Average True Range (ATR)
  • MIST 0.09
  • AMPY 0.17
  • MACD
  • MIST 0.01
  • AMPY -0.02
  • Stochastic Oscillator
  • MIST 90.91
  • AMPY 52.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

Share on Social Networks: